Pacer Advisors, Inc.

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1616667 Malvern, PA

Position in HRMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,679,381

+$3,757,440 QoQ

Shares Held

348,239

+9.3% QoQ

Ownership

0.598%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#30

of 319 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pacer Advisors, Inc. holds $626,865,233 across 140 Biotechnology names. HRMY ranks #8 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	369,451	$230,367,476
2	INCY	Incyte Corp	1,431,426	$162,266,451
3	EXEL	Exelixis, Inc.	1,096,682	$59,670,467
4	VRTX	Vertex Pharmaceuticals Inc / Ma	72,465	$35,995,539
5	JAZZ	Jazz Pharmaceuticals plc	146,264	$35,245,236
6	BMRN	Biomarin Pharmaceutical Inc	506,545	$28,984,504
7	HALO	Halozyme Therapeutics, Inc.	228,060	$17,850,256
8	HRMY	Harmony Biosciences Holdings, Inc. This page	348,239	$12,679,381

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,679,381	348,239	+9.3%	Shares	Sole	2026-08-13
2026-03-31	$8,921,941	318,527	+9.7%	Shares	Sole	2026-06-18
2025-12-31	$10,865,009	290,353	-20.0%	Shares	Sole	2026-02-24
2025-09-30	$10,002,846	362,948	-4.5%	Shares	Sole	2025-10-15
2025-06-30	$12,012,898	380,155	-23.5%	Shares	Sole	2025-08-12
2025-03-31	$16,494,069	496,959	-78.2%	Shares	Sole	2025-05-06
2024-12-31	$78,451,978	2,279,918	+18.2%	Shares	Sole	2025-01-22
2024-09-30	$77,133,440	1,928,336	-23.2%	Shares	Sole	2024-11-12
2024-06-30	$75,714,903	2,509,609	+0.6%	Shares	Sole	2024-08-13
2024-03-31	$83,779,212	2,494,914	+103.7%	Shares	Sole	2024-05-10
2023-12-31	$39,564,593	1,224,910	+534795.2%	Shares	Sole	2024-01-16
2023-09-30	$7,504	229	-99.9%	Shares	Sole	2023-11-13
2023-06-30	$15,367,648	436,705	—	Shares	Sole	2023-07-12
No filing history on record for this holder in this stock.